Skip to main navigation Skip to search Skip to main content

Speech differences between multiple system atrophy and Parkinson's disease

Tom Hähnel, Anna Nemitz, Katja Schön, Luise Berger, Annemarie Vogel, Doreen Gruber, Nils Schnalke, Stefan Bräuer, Björn H. Falkenburger, Florin Gandor

Research output: Contribution to journalArticlepeer-review

63 Downloads (Pure)

Abstract

Background: Delineation of Parkinson's disease (PD) from multiple system atrophy (MSA) can be challenging in early disease stages. Speech characteristics have been studied as digital biomarkers in PD and ataxias. Currently, data on speech in MSA is limited.

Objectives: To determine whether speech characteristics can serve as a digital biomarker to differentiate between MSA and PD.

Methods: Twenty-one MSA patients and 23 PD patients underwent a battery of speech assessments: text reading, sustained phonation and diadochokinetic tasks. Speech characteristics were extracted using the software, Praat.

Results: MSA and PD speech can be described by three meaningful factors. MSA speech exhibited more reading pauses, higher pitch variability, prolonged syllables, and a more irregular speech rhythm, allowing differentiation from PD with a ROC-AUC of 0.89. Speech characteristics were correlated with motor impairment and disease severity.

Conclusion: MSA can be differentiated from PD with good accuracy using speech analysis.

Original languageEnglish
Pages (from-to)1391-1397
Number of pages7
JournalMovement Disorders Clinical Practice
Volume12
Issue number9
Early online date3 May 2025
DOIs
Publication statusPublished - Sept 2025

Bibliographical note

Copyright the Author(s) 2025. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • voice
  • Parkinson's disease
  • speech
  • multiple system atrophy
  • dysarthria

Fingerprint

Dive into the research topics of 'Speech differences between multiple system atrophy and Parkinson's disease'. Together they form a unique fingerprint.

Cite this